Hear-Wear Technologies, LLC v. Oticon, Inc.

551 F. Supp. 2d 1272, 2008 U.S. Dist. LEXIS 17636, 2008 WL 656001
CourtDistrict Court, N.D. Oklahoma
DecidedMarch 6, 2008
Docket07-CV-0212-CVE-SAJ
StatusPublished

This text of 551 F. Supp. 2d 1272 (Hear-Wear Technologies, LLC v. Oticon, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hear-Wear Technologies, LLC v. Oticon, Inc., 551 F. Supp. 2d 1272, 2008 U.S. Dist. LEXIS 17636, 2008 WL 656001 (N.D. Okla. 2008).

Opinion

OPINION AND ORDER

CLAIRE V. EAGAN, Chief Judge.

Now before the Court is Plaintiffs Motion to Dismiss Defendant Oticon, Inc.’s Amended Antitrust Counterclaims and Brief in Support Thereof (Dkt.# 97). Plaintiff Hear-Wear Technologies, LLC (“Hear-Wear”) moves to dismiss defendant Oticon, Inc.’s (“Oticon”) second and third amended counterclaims pursuant to Fed.R.Civ.P. 12(b)(6). Hear-Wear argues that Oticon’s claims are not supported by plausible factual allegations. For the reasons set forth below, the Court finds that Hear-Wear’s motion should be denied.

I.

This civil action arises from the alleged infringement of four of Hear-Wear’s hearing aid patents (“Patents”). Dkt. #2, at 5-6. Hear-Wear claims that Oticon and its co-defendants, who are manufacturers of a variety of hearing aid products, willfully and deliberately infringed the Patents. Id. at 6. As a result of such infringement, Hear-Wear filed suit on April 6, 2007, seeking declaratory and injunctive relief, compensatory and “enhanced” damages, and attorneys’ fees and costs. Dkt. # 2, at 7. Oticon and its co-defendants aver that their hearing aid products do not infringe the Patents and that the Patents are invalid and unenforceable. Dkt. # 51, at 10-11; Dkt. # 64, at 6; Dkt. # 88, at 12; Dkt. # 113, at 6.

On October 1, 2007, Oticon filed its amended answer and counterclaims. See Dkt. # 88. Only the second and third amended counterclaims, pled in the alternative, are relevant to the inquiry here. *1275 In the second amended counterclaim, Oti-con alleges that Hear-Wear is attempting to monopolize the relevant market in violation of the Sherman Antitrust Act, 15 U.S.C. § 2. Id. at 50. In the third amended counterclaim, Oticon alleges that Hear-Wear is attempting to monopolize the relevant market in violation of the Oklahoma Antitrust Reform Act, OKLA. STAT. tit. 79, §§ 201-212. Id. at 92. Oticon defines the relevant geographic market as the United States for its federal claim and as the State of Oklahoma for its state claim. Id. at 50, 92. According to Oticon, Hear-Wear is attempting to monopolize these markets: (1) by wrongfully attempting to enforce two of the Patents, which Oticon claims were obtained by fraud on the United States Patent and Trademark Office (“PTO”), id. at 56, 70, 93, and (2) by engaging in this sham litigation, id at 88, 90, 93. Oticon’s remaining allegations are the same for both amended counterclaims.

Oticon defines the relevant product market as “the market for hearing aids combining behind-the-ear [BTE] components with receiver-in-the-ear [RITE] components ... commonly referred to ... as ‘BTE/RITE’ hearing aid types.” Id. at 50, 92. The relevant product market includes “all such hearing aids sold with electronic receiver ... intended for ‘shallow’ or ‘deep’ insertion, and includes the market for BTE/RITE hearing aids with both an ‘open’ and ‘closed’ fit solution in combination with either a ‘deep’ or ‘shallow’ insertion.” Id. at 51, 93. Oticon claims that the substitutes for Hear-Wear’s products in the relevant product market include “the Oticon Delta and Epoq, the Phonak microPower, the Interton Shape (also a GN ReSound product) and the Vivatone Entré, including various models of those product lines, which are reasonable alternatives and includable in the market.” Id at 51, 94. As for cross-elasticity of demand, Oticon states that “[t]hese products are reasonably interchangeable from an antitrust standpoint within the relevant market due to their similar utility, efficiency, reliability, responsiveness, continuity, and user preference for aesthetics, comfort, and performance attributes, and consumers treat them as acceptable substitutes.” Id. at 51, 94. Oticon further states that no other close or effective substitutes exist. Id. at 51, 94.

The only alleged competitors in the relevant product and geographic markets are Hear-Wear, Oticon, and four co-defendants who, all combined, purportedly constitute about 99% of sales in these markets. Id. at 52, 95. Oticon alleges that high barriers, such as large capital requirements and significantly prolonged product-development periods, preclude entry of new competitors into the BTE/RITE hearing aid industry. Id. at 52, 95. Oti-con claims that if Hear-Wear is successful in this suit, “there is a realistic and dangerous probability that Hear-Wear will achieve a monopoly of essentially 100% of the BTE/RITE market in the United States.” Id. at 52, 95. Allegedly, Hear-Wear then will be able to “arbitrarily raise prices and/or reduce production of BTE/ RITE hearing aids,” forcing market consumers with no other alternatives “to pay the price demands of Hear-Wear.” Id. at 52-53, 95.

Oticon claims that Hear-Wear’s specific intent to violate “United States anti-trust laws” is demonstrated by Hear-Wear’s fraud on the PTO and initiation of this allegedly sham lawsuit. Id. at 53, 95-96. These actions allegedly “have had an anti-competitive effect and have intentionally caused injury to competition beyond its impact on Oticon.” Id. at 54, 96. Oticon and its co-defendants allegedly have suffered direct and substantial injuries as an immediate result of HearWear’s antitrust violations. Id. at 55, 97.

*1276 Hear-Wear moves to dismiss Oticon’s second and third amended counterclaims pursuant to Fed.R.Civ.P. 12(b)(6). Hear-Wear avers that these amended counterclaims contain no factual allegations whatsoever to support Oticon’s geographic and product market definitions. Dkt. # 97, at 8-9. Thus, according to Hear-Wear, Oti-con’s attempted monopolization counterclaims should be dismissed. Id. at 9.

II.

A motion to dismiss is properly granted when a complaint or counterclaim provides no “more than labels and conclusions, and a formulaic recitation of the elements of a cause of action.” Bell Atlantic Corp. v. Twombly, — U.S. -, 127 S.Ct. 1955, 1965, 167 L.Ed.2d 929 (2007). In considering a motion to dismiss under Fed.R.Civ.P. 12(b)(6), a court must determine whether the claimant has stated a claim upon which relief may be granted. The factual allegations within the claim “must be enough to raise a right to relief above the speculative level.” Id. (citations omitted). “Once a claim has been stated adequately, it may be supported by showing any set of facts consistent with the allegations in the complaint [counterclaim].” Id. at 1969. For purposes of making the dismissal determination, a court must accept all the well-pleaded allegations of the claim as true, even if doubtful in fact, and must construe the allegations in the light most favorable to the claimant. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
551 F. Supp. 2d 1272, 2008 U.S. Dist. LEXIS 17636, 2008 WL 656001, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hear-wear-technologies-llc-v-oticon-inc-oknd-2008.